Please provide your email address to receive an email when new articles are posted on . HPV-based vs. cytology-based screening was tied to lower risks for invasive cervical cancer. Adverse events were ...
EL MUNDO on MSN
A menstrual blood test can detect the papillomavirus
The test could serve as an alternative in cervical cancer screening, cytology, according to a new study. Certain types of ...
Hologic receives US FDA approval for Aptima HPV assay for primary screening option; expands cervical health portfolio: Marlborough, Massachusetts Saturday, February 7, 2026, 12:00 ...
The FDA has expanded the approval of Hologic’s Aptima human papillomavirus (HPV) assay for clinician-collected primary ...
Objective To compare the diagnostic accuracy of minipad collected menstrual blood versus clinician collected cervical samples to test for human papillomavirus (HPV) in the detection of cervical ...
In May 2024, the Food and Drug Administration (FDA) approved two new cervical screening tests for detecting human papillomavirus (HPV), which causes almost all cervical cancers. Both allow individuals ...
This Collection supports and amplifies research related to SDG 3 - Ensure healthy lives and promote well-being for all at all ages. As a leading cause of death, cancer control remains a tough ...
Hologic, Inc. (Nasdaq: HOLX) announced today that its Aptima ® HPV Assay received FDA approval for clinician-collected HPV primary screening. Hologic’s human papillomavirus (HPV) test is the only ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results